| Synonyms: | |
| Status: | Phase 3 |
| Entry Type: | Antibody |
| Molecule Category: | UNKNOWN |
| UNII: | 51WEW898IJ |
Pharmacology
| Action | Mechanism of Action | Reference |
|---|---|---|
| INHIBITOR | Hepatocyte growth factor inhibitor | PubMed |
Indications
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Stomach Neoplasms | 3 | D013274 | ClinicalTrials |
| Carcinoma, Renal Cell | 2 | D002292 | ClinicalTrials |
| Carcinoma, Squamous Cell | 2 | D002294 | ClinicalTrials |
| Gliosarcoma | 2 | D018316 | ClinicalTrials |
| Glioma | 2 | D005910 | ClinicalTrials |
| Mesothelioma | 2 | D008654 | ClinicalTrials |
| Prostatic Neoplasms, Castration-Resistant | 1 | D064129 | ClinicalTrials |
| Small Cell Lung Carcinoma | 1 | D055752 | ClinicalTrials |
Cross References
| Resources | Reference |
|---|---|
| CAS NUMBER | 872514-65-3 |
| ChEMBL | CHEMBL1743063 |
| FDA SRS | 51WEW898IJ |
| Guide to Pharmacology | 7986 |
CONTENTS